Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Ocuphire Pharma, Inc. | ex32_2.htm |
EX-32.1 - EXHIBIT 32.1 - Ocuphire Pharma, Inc. | ex32_1.htm |
EX-31.2 - EXHIBIT 31.2 - Ocuphire Pharma, Inc. | ex31_2.htm |
EX-31.1 - EXHIBIT 31.1 - Ocuphire Pharma, Inc. | ex31_1.htm |
EX-24.1 - EXHIBIT 24.1 - Ocuphire Pharma, Inc. | ex24_1.htm |
EX-23.1 - EXHIBIT 23.1 - Ocuphire Pharma, Inc. | ex23_1.htm |
EX-10.8 - EXHIBIT 10.8 - Ocuphire Pharma, Inc. | ex10_8.htm |
10-K - 10-K - Ocuphire Pharma, Inc. | form10k.htm |
Exhibit 12.1
Statement Regarding the Computation of Ratio of Earnings to Combined Fixed Charges and Preferred Stock Dividends
Our earnings are inadequate to cover fixed charges. The following table sets forth the dollar amount of the coverage deficiency (in thousands) for the periods presented.
For the Year Ended December 31,
|
||||||||||||||||||||
Statement of Operations Data:
|
2017
|
2016
|
2015
|
2014
|
2013
|
|||||||||||||||
Earnings:
|
||||||||||||||||||||
Net loss
|
$
|
(25,295
|
)
|
$
|
(9,307
|
)
|
$
|
(14,385
|
)
|
$
|
(18,522
|
)
|
$
|
(9,499
|
)
|
|||||
Plus fixed charges
|
80
|
81
|
78
|
68
|
61
|
|||||||||||||||
Total loss to cover fixed charges
|
(25,215
|
)
|
(9,226
|
)
|
(14,307
|
)
|
(18,454
|
)
|
(9,438
|
)
|
||||||||||
Fixed Charges:
|
||||||||||||||||||||
Interest portion of rental expense (see below)
|
80
|
81
|
78
|
68
|
61
|
|||||||||||||||
Deficiency of earnings to cover fixed charges
|
(25,295
|
)
|
(9,307
|
)
|
(14,385
|
)
|
(18,522
|
)
|
(9,499
|
)
|
The estimate of the interest portion of rental expense is calculated as one-third of the total rental expense for the period.